文献速递冠心病心力衰竭与心肌病

外周动脉疾病对心肌梗死合并心源性休克患者结局的影响

Outcomes Associated With Peripheral Artery Disease in Myocardial Infarction With Cardiogenic Shock.
PubMed 文献 · J Am Coll Cardiol · 2022-01-01

该研究基于2015至2018年住院的医保受益人数据,分析了合并下肢外周动脉疾病(PAD)对急性心肌梗死(AMI)合并心源性休克(CS)患者结局的影响。结果显示,PAD患者院内死亡、截肢及院外死亡风险均显著更高,且接受机械循环支持(MCS)的比例更低、结局更差。

要点

  • 合并PAD的AMI-CS患者院内死亡率更高(56.3% vs 46.6%,调整OR 1.50)。
  • PAD患者截肢风险显著增加(调整OR 7.0),院外死亡风险亦升高(调整HR 1.78)。
  • PAD患者接受MCS的比例更低,且接受MCS后死亡、截肢风险更高。

核心结论

  • 在AMI合并CS患者中,PAD与更差的肢体结局和生存率相关。
  • PAD患者接受MCS的比例较低,且接受MCS后死亡、下肢血运重建和截肢风险增加。

研究设计与样本

  • 共纳入71,690例AMI合并CS患者,其中5.9%(4,259例)合并PAD。
  • 主要结局为院内和院外死亡,次要结局包括出血、截肢、卒中和下肢血运重建,采用多因素回归调整混杂因素。

主要发现

  • 总体院内累积死亡率为47.2%,PAD患者为56.3%,非PAD患者为46.6%(调整OR 1.50;95%CI 1.40-1.59)。
  • PAD患者院内截肢率为1.6%,非PAD患者为0.2%(调整OR 7.0;95%CI 5.26-9.37)。
  • PAD患者院外死亡率为67.9%,非PAD患者为40.7%(调整HR 1.78;95%CI 1.67-1.90)。
  • PAD患者接受MCS的比例为21.5%,非PAD患者为38.6%(P < 0.001)。
  • 在接受冠脉血运重建的患者中,上述关联保持一致。

临床怎么用

  • 对AMI合并CS患者应评估是否合并下肢PAD,以识别肢体结局和死亡高风险人群。
  • PAD患者接受MCS时需警惕更高的死亡、下肢血运重建和截肢风险,个体化权衡获益与风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Mortality rates for patients presenting with acute myocardial infarction (AMI) and cardiogenic shock (CS) remain high despite advances in revascularization strategies and mechanical circulatory support (MCS) devices. OBJECTIVES: This study sought to elucidate the association between comorbid lower extremity peripheral artery disease (PAD) and outcomes in CS and AMI. METHODS: PAD status was defined in Medicare beneficiaries hospitalized with CS and AMI from October 1, 2015 to June 30, 2018. Primary outcomes ascertained through December 31, 2018 included in- and out-of-hospital mortality. Secondary outcomes included bleeding, amputation, stroke, and lower extremity revascularization. Multivariable regression models with adjustment for confounders were used to estimate risk. Subgroup analyses included patients treated with MCS and those who underwent coronary revascularization. RESULTS: Among 71,690 patients, 5.9% (N = 4,259) had PAD. Mean age was 77.8 ± 7.9 years, 58.7% were male, and 84.3% were White. Cumulative in-hospital mortality was 47.2%, with greater risk among those with PAD (56.3% vs 46.6% without PAD; adjusted OR: 1.50; 95% CI: 1.40-1.59). PAD patients also had greater risk of in-hospital amputation (1.6% vs 0.2%; adjusted OR: 7.0; 95% CI: 5.26-9.37) and out-of-hospital mortality (67.9% vs 40.7%; adjusted HR: 1.78; 95% CI: 1.67-1.90). MCS was less frequently utilized in PAD patients (21.5% vs 38.6% without PAD; P < 0.001) and was associated with higher mortality, need for lower extremity revascularization, and amputation risk. Findings were consistent in patients who underwent coronary revascularization. CONCLUSIONS: Among patients presenting with AMI and CS, PAD was associated with worse limb outcomes and survival. In addition to lower MCS utilization rates, those with PAD who received MCS had increased mortality, lower extremity revascularization, and amputation rates.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Mihatov, Mosarla, Kirtane, et al. Outcomes Associated With Peripheral Artery Disease in Myocardial Infarction With Cardiogenic Shock. J Am Coll Cardiol. 2022. PMID: 35361344. doi:10.1016/j.jacc.2022.01.037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。